TC
BIVV

Telemus Capital’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Telemus Capital’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-114
Closed -$6K – 611
2017
Q4 		$6K Buy
+114
New +$6.24K ﹤0.01% 551

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Telemus Capital's BIVV Position: Q1 2018 in Review

Telemus Capital sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 114 shares — an estimated $6K sold.

Telemus Capital first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $6K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Telemus Capital reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Telemus Capital sold 114 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
  • Telemus Capital first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Telemus Capital's Bioverativ Inc. Common Stock position peaked at $6K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Telemus Capital's 13F filing for Q1 2018, filed 27 Apr 2018.